ArticleCancer chemotherapy and pharmacology2024

Immunoregulatory cyclophilin a improves low-dose chemotherapy with a modulation of the immune tumor microenvironment in experimental models of melanoma B16 and lymphoma EL4 in vivo.

Anastasiia A Kalinina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.